Peer-reviewed preclinical melanoma research finds Provectus’s synthetic small molecule can both stimulate anti-tumor immunity and suppress ...
Every investor is looking for opportunities, but finding promising stocks and deciding when to buy is rarely a simple task. Successful investing often depends on separating temporary market moves from ...
Brii Bio announces positive end-of-treatment results from phase 2b ENRICH & ENHANCE studies to treat chronic hepatitis B: Durham, North Carolina Monday, July 6, 2026, 18:00 Hrs [I ...
Abstract: Tiny AI-edge devices use nvCIM for power-off weight storage and active-mode computation, enabling high energy efficiency (EF) and low power-on latency. While tiny Transformer models offer ...
Global hepatitis report 2024: action for access in low- and middle-income countries. World Health Organization. Retrieved from ...
DURHAM, N.C. and BEIJING, July 3, 2026 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient ...
Abstract: The current sequential recommendation systems mainly focus on mining information related to users to make personalized recommendations. However, there are two subjects in the user historical ...